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Abstract
Background: Peripheral venous cannulation is an everyday practice in hospitals, which many adults find painful.
However, anaesthesia for cannulation is usually only offered to children. Inadequate pain relief is not only unpleasant
for patients but may cause anxiety about further treatment and deter patients from seeking medical care in the future.
The aim of this study is to discover the most effective local anaesthetic for adult peripheral venous cannulation and to
find out how the pain of local anaesthetic application compares with that of unattenuated cannulation.
Methods: These aims are addressed through a systematic review, network meta-analysis and random-effects
meta-analysis. Searching covered 12 databases including MEDLINE and EMBASE from 1990 to August 2015. The
main included study design was RCTs. The primary outcome measure is self-reported pain, measured on a
100 mm visual analogue scale.
Results: The systematic review found 37 includable studies, 27 of which were suitable for network meta-analysis
and two for random-effects meta-analysis. The results of the network meta-analysis indicate that none of the 17
anaesthetic considered had a very high probability of being the most effective when compared to each other; 2 %
lidocaine had the highest probability (44 %). When the anaesthetics were compared to no treatment, the network
meta-analysis showed that again 2 % lidocaine was estimated to be the most effective (mean difference −25.42
(95 % CI −32.25, −18.57). Other members of the ‘caine’ family were also estimated to be more effective than no
treatment as were Ametop®, EMLA® and Rapydan® patch. The meta-analysis compared the pain of anaesthetic
application with the unattenuated pain of cannulation. This found that all applications of local anaesthetic were less
painful than cannulation without local anaesthetic. In particular a 1 % lidocaine injection was estimated to be −12.97
(95 % CI −15.71, −10.24) points (100 mm VAS) less painful than unattenuated cannulation.
Conclusions: The pain of peripheral venous cannulation in adults can be successfully treated. The pain of application
of any local anaesthetic is less than that of unattenuated cannulation. Local anaesthetic prior to cannulation should
become normal practice and a marker of high quality care.
Protocol registration: The protocol for the larger study was registered with PROSPERO no. CRD42012002093.
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Background
First do no harm. It can be argued that causing unneces-
sary pain during medical procedures is doing harm. One
example is the routine insertion of peripheral venous
cannulae (PVC). This procedure is a common experience
for thousands of patients and reported by adults to be
painful [1]. Although it is normal practice to provide local
anaesthesia for children prior to PVC it is unusual for this
to be offered to adults.
Inadequate pain relief is unpleasant for the patient but
may also increase anxiety about future treatment and
deter patients from seeking help in the future [2–5]. Fear
of the procedure can trigger an autonomic response,
which can result in vasoconstriction [6, 7]. This has the
potential to cause reduced venous access, potentially
making PVC more difficult for the practitioner leading
to several attempts at insertion, thus increasing the risk
of infection and other complications [8–10].
A survey investigating the use of local anaesthesia for
adult PVC questioned 178 hospital doctors. It found that
all the anaesthetists used local anaesthetic when inserting
cannulae larger than 18 gauge, but less than half medical
and surgical doctors did so [11]. Another survey of 71 jun-
ior doctors’ use of and attitudes to pain relief for adult
PVC gave some reasons for this discrepancy. It showed
that 35 % of junior doctors sometimes used a local anaes-
thetic. However, those using local anaesthetic only did so
on average for 6 % of the time. Most of these used injected
lidocaine (84 %) others used eutectic mixture local anaes-
thetics (EMLA®) cream (48 %) with 36 % using either
agent. The 65 % who never used a local anaesthetic for
PVC in adults gave a variety of reasons for this, including
that it was, too time consuming (45 %), not indicated
(35 %), made PVC more difficult (21 %), not available
(13 %), logistically difficult (13 %), against peer pressure
(4 %), not allowed (4 %) and practically difficult (4 %) [12].
Although trials have been conducted comparing various
local anaesthetic agents for adult PVC [13–17] and there
have been two meta-analyses in the adult population, one
of lidocaine and one of EMLA® [18, 19] it remains
unknown which of the many agents in use is the most
effective. This paper represents some of the findings of
a larger systematic review, which aimed to address this
knowledge gap [20]. This larger report is available on
request from the authors.
Methods
Aim
The aim of this research paper is to answer the following
research questions:
1 What is the most effective local anaesthetic for
reducing the pain of PVC in adults in routine
(non-emergency) settings?
2 How does the pain of local anaesthetic application
compare with that of routine (non-emergency)
unattenuated PVC in adults?
We answered these questions by conducting a systematic
review, network meta-analysis and random-effects meta-
analysis.
The systematic review was carried out following the
principles published by the National Health Service
(NHS) Centre for Reviews and Dissemination [21].
Eligibility criteria
Eligible studies included both controlled trials and ob-
servational studies that compared the use of a local an-
aesthetic prior to PVC with no local anaesthetic prior
to PVC in adults in secondary care receiving routine
PVC (non-emergency). The primary outcome measure
was self-reported pain.
Search strategy
The search strategy was developed by a professional In-
formation Specialist (CC) and is provided in Additional
file 1. The database searches were conducted in March
2012 and updated in June 2013, September 2014 and
August 2015 using a protocol driven search. The fol-
lowing bibliographic resources were searched: MED-
LINE, MEDLINE-IN-Process, EMBASE, PsycINFO,
Health Management Information Consortium (HMIC),
Social Policy and Practice (all via OVID), Applied So-
cial Sciences Index and Abstracts (ASSIA), Sociological
Abstracts (via ProQuest), Cumulative Index to Nursing
and Allied Health Literature (CINAHL) (via Ebsco
Host), British Nursing Index (via NHS Evidence), Web
of Science (via Thomson Reuters) and the Cochrane
library. Database searching was limited by date (1990-
Current) and to human only populations. No further
limits were used.
Web and grey literature searching was conducted
using both Google and the meta-search engine Dogpile.
The following web-sites were also searched: The Patients
Association, NHS Evidence, National Institute for Health
and Care Excellence (NICE), Current Controlled Trials,
and Clinical Trials.gov. Citation chasing and contact
with experts was used on publications included in the
searches.
Study selection, data extraction and quality assessment
Titles and abstracts were screened independently by
three researchers (LC, MB and HC) against the inclusion
criteria. Papers selected for full-text review underwent
the same process. Data were extracted from included
studies by one reviewer and checked by another. Study
authors were contacted as necessary.
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The risk of bias was assessed using the appropriate
tool for the design of the study; the CONSORT (Consoli-
dated Standards of Reporting Trials) statement [22] for
randomised controlled trials (RCTs) and controlled trials,
and the STROBE (STrengthening the Reporting of
OBservational studies in Epidemiology) statement [23]
for observational studies. External validity was judged
according to the applicability of findings to the relevant
patient group and service setting.
Statistical analysis
The heterogeneity of RCTs was initially explored by
assessing study population, methods and interventions.
The principal summary measure was mean differences
in self-reported pain. This was assumed to be linear on
either 0–10 or 0–100 scales. To assist with the interpret-
ation of the results, all responses on the scales were
linearly rescaled to a range of 0–100. Thus, a mean dif-
ference between groups of −10 would indicate that post-
intervention pain was 10 units lower in the intervention
group compared with the control group. As some stud-
ies used medians to summarise their results, to allow
analysis we transformed all estimates to means and
standard deviations [24]. To address the first question a
network meta-analysis (NMA) was undertaken to com-
pare multiple treatments directly and indirectly, within
and across trials. A model with normal likelihood and an
identity link was used. All prior distributions were
intended to be vague. Both a fixed effects and a random
effects NMA model were run, but as the deviance infor-
mation criteria suggested a better fit to the random effects
model, only the results from the random effects model are
reported here [25]. An analysis of the consistency of esti-
mates derived from the direct and indirect evidence was
also done [26]. The NMA was undertaken in WinBUGS.
Analyses were run with three chains, and model conver-
gence was assessed by visual inspection of density and
autocorrelation plots, and checking that all three chains
were sampling from the same posterior distribution.
As only two studies were eligible to answer the second
question a fixed effects pairwise meta-analysis was under-
taken in Stata SE 12 (Texas USA). Statistical heterogeneity
was assessed by the I2 statistic. Formal evaluation of the
risk of publication bias was not conducted for those
studies included in addressing question one due to a
lack of methods for assessing the risk of publication
bias in NMAs. As there were only two studies eligible
to answer Question 2, formal evaluation of the risk of
publication bias was not conducted.
Results
The initial searches found 16,368 titles and abstracts
after deduplication. Following screening 465 papers were
requested for further review; of these 20 were not
obtainable. Of the 445 papers obtained 31 were found to
meet the inclusion criteria. Reasons for exclusion can be
found in Fig. 1. Update searches (September 2014 and
August 2015) identified six additional studies, giving a
total of 37 primary research studies. Thirty two were
randomised controlled trials [1, 13–17, 27–52], four were
controlled trials [53–56]} and one was a survey [57].
The primary outcome, pain, was measured in a variety
of ways including: a visual analogue scale (VAS) (n = 22
studies [1, 14–17, 27, 30–32, 35, 37, 39–41, 43, 44, 46–
49, 51–53, 56]), a numerical rating scale (n = 6, [13, 29,
34, 38, 50, 54]), Wong Baker Faces (n = 1, [28]) and,
other (n = 4 [30, 33, 36, 45]). Four studies reported that
participants had been given pre-medication prior to
PVC [29, 42, 45, 47]. Cannulae were placed in the fol-
lowing sites: the dorsum of the hand (n = 27 [1, 13–17,
27, 29, 31, 32, 34–52, 54, 55]), the forearm (n = 12 [13,
28, 31, 33, 40, 49–52, 55, 56]), the wrist (n = 4 [31, 39,
40, 55]), and the anticubital fossa (n = 5 [13, 31, 39, 40,
52]). The location was not reported in three studies. The
gauge of the cannulae ranged from 16 to 23, with 15
studies using an 18 gauge cannula [13, 14, 17, 27, 29, 31,
33, 34, 37, 39, 41–43, 46–48, 55], seven using a 20 gauge
cannula [1, 13, 15, 30, 32, 44, 49, 54], and five studies
not reporting the size of the cannula. A description of
the local anaesthetics used in the included studies can
be found in Additional file 2. Note than iontocaine is a
compound containing 2 % lidocaine. A summary of the
studies characteristics can be found in Additional file 3.
Quality of evidence
The included studies varied in the quality of their report-
ing of the risk of bias. Type of randomisation, methods
used to generate the random sequence, allocation conceal-
ment, and blinding were often not reported fully or at all.
However, the statistical methods used for the primary ana-
lysis were clear and the estimates of mean differences
with precision were generally reported. Additionally,
the studies varied in size, ranging from 26 [39] to 450
[42] participants. Additional files 4–5 provide a sum-
mary critical appraisal of included studies.
Study results
A summary of results from the included studies can be
found in Additional file 6.
Question 1. What is the most effective local anaesthetic for
reducing the pain of PVC in adults in routine settings?
The NMA included 27 RCTs [1, 13, 15, 17, 27–38, 40, 41,
43–46, 48–52]. The other five RCTs were not included in
the NMA because four did not provide enough informa-
tion to be able to calculate standard deviations when trans-
forming medians to means (Saxena [14], Agarwal [16, 42],
Gupta [47]), and one concerned duration of anaesthetic
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application [39]. The included studies evaluated the fol-
lowing local anaesthetics: lidocaine 2 %, lidocaine 1 %,
buffered lidocaine 1 %, lidocaine + methylparaben, lido-
caine + NaCHO3, iontocaine, bupivacaine, Rapydan®,
EMLA®, Ametop®, buffered saline, ethyl chloride, chloro-
procaine, dichlorotetrafluoroethane, diclofenac, saline, pla-
cebo and no treatment. The network of included studies
can be seen in Fig. 2. Note that many of the comparisons
are just informed by one or two studies.
None of the treatments had a high probability of being
the most effective compared to all of the treatments
evaluated in the network. Two percent lidocaine had the
highest probability of being the most effective treatment
(44 %), followed by lidocaine +methylparaben (17 %) and
iontocaine (15 %). Most treatments had a probability <1 %
of being the most effective treatment, this included
EMLA®, 1 % lidocaine, and Ametop®. The order of the
rankings can be found in Additional file 7.
The forest plots from the NMA results give a clearer
picture of the anaesthetics’ relative effectiveness. We
examined all comparisons with no treatment, 2 % lido-
caine, 1 % lidocaine, EMLA® and Ametop® cream as the
comparators, see Figs 3–7. These comparators are chosen
because they are commonly used in practice. Forest
plots that have the other agents as comparators can be
found in Additional file 8.
A word of caution is needed for the interpretation of
the forest plots. Frequently the confidence intervals
cross zero, casting doubt over the reliability of the point
estimate. Even more frequently, the confidence intervals
of different comparisons overlap each other; making it
difficult to clearly say which is the best treatment. This
reflects the finding that no single treatment has a high
probability of being the most effective.
When all of the agents are compared with no treatment
(Fig. 3), the majority are estimated to be more effective
at reducing pain than no treatment. In particular, 2 %
lidocaine is estimated as the most effective (mean differ-
ence, −25.42 (95 %CI −32.25, −18.57). An examination
of this plot shows that members of the ‘caine’ family of
drugs are estimated to be much more effective than no
treatment, as are Ametop®, EMLA® and Rapydan patch.
When 2 % lidocaine is compared with all the other local
anaesthetics in a NMA (Fig. 4), the point estimates suggest
Fig. 1 Flowchart of studies through the screening process
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2 % lidocaine to be more effective than any other agent.
However, the evidence suggests that iontocaine, lid +me-
thyl, Lid +NaCHO3, Bupivacaine, 1 % lid, Rapydan®, Ame-
top® and buffered lidoacine could be as effective as 2 %
lidocaine. The evidence suggests that 2 % lidocaine is more
effective than diclofenac, saline and placebo treatments.
When all the local anaesthetics are compared to 1 %
lidocaine, there is little evidence to suggest that 2 % lido-
caine and 1 % lidocaine with additional agents, may be
more effective than 1 % lidocaine on its own. However,
what is clear is that placebo treatments, diclofenac and sa-
line are likely to be less effective than 1 % lidocaine (Fig. 5).
Fig. 3 NMA forest plot vs. no treatment
Fig. 2 Network diagram
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Fig. 4 NMA forest plot vs. lidocaine 2 %
Fig. 5 NMA forest plot vs. lidocaine 1 %
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Local anaesthetic creams are an alternative to injec-
tions. Two commonly used are EMLA® and Ametop®.
Figure 6 has EMLA® as the comparator. This figure
shows that EMLA® is likely to be superior to diclofenac,
saline, and placebo. Further, this figure indicates that
EMLA® is less effective than 2 % lidocaine, but it is un-
clear whether EMLA® is less effective than Ametop®
(−3.01 (−10.22, 4.22)).
When Ametop® cream is the comparator, in Fig. 7 a
similar profile is seen to Fig. 7. However, there is a shift
in the point estimates that may indicate that overall
Ametop® is more effective than EMLA®, compared to
other agents, at reducing the pain of PVC.
Question 2. How does the pain of local anaesthetic
application compare with that of routine (non-emergency)
unattenuated PVC in adults?
Six RCTs compared the pain of local anaesthetic ad-
ministration with that of routine (non-emergency) un-
attenuated PVC [1, 37, 38, 40, 49, 52]. A summary of
these studies results can be found in Additional file 9.
However, only two had ‘no treatment’ control groups,
which is necessary to address this question [1, 52].
Windle et al. compared 1 % lidocaine and saline with
unattenuated PVC; Selby et al. compared 1 % lidocaine,
ethyl chloride and EMLA® with unattenuated PVC. For
the comparison of 1 % lidocaine with unattenuated
PVC, a fixed effects meta-analysis of the data from
Windle and Selby was conducted. For all comparisons,
the pain of anaesthetic application was less than that of
unattenuated PVC. An injection of lidocaine 1 % was
estimated to be −12.97 (95 % CI −15.71, −10.24) points as
painful, an injection of saline with benzyl alcohol −16.32
(95 % CI −25.44, −7.20) points as painful, ethyl chloride
spay −14.00 (95 % CI −17.12, −10.88) points as painful
and EMLA® cream −23.50 (95 % CI −26.27, −20.73) points
as painful as cannulation without treatment, measured on
a 100 mm VAS. See Fig. 8.
Analysis of the consistency of the network indicated
some evidence of inconsistency (i.e. direct and indirect
evidence suggesting different conclusions), and this was
seen for the placebo cream vs no treatment comparison
(see Additional file 10).
Discussion
A total of 37 studies met the inclusion criteria for this
review. Twenty seven had data suitable for the NMA
and two suitable for the meta-analysis.
The results of the NMA for effectiveness indicate that
none of the local anaesthetics can unequivocally be held
as the most effective at reducing the pain of PVC. How-
ever, the analysis suggests that the majority of active
treatments are effective at reducing pain compared to no
treatment, with 2 % lidocaine, iontocaine, lid + methyl,
Lid + NaCHO3, Bupivacaine, 1 % lid, Rapydan®, Ametop®
and buffered lidoacine likely to be the most effective.
Fig. 6 NMA forest plot vs. EMLA cream
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Fig. 7 NMA forest plot vs. ametop cream
Fig. 8 Meta-analysis of studies comparing pain of anaesthetic administration with unattenuated PVC
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One unexpected result of the NMA is the apparent
greater effectiveness of 1 % lidocaine over 1 % buffered
lidocaine (4.16 (95 % CI −4.78, 12.83)). There are a num-
ber of possible influences on this result. Firstly, there are
no direct comparisons of buffered and normal lidocaine,
so this result comes from indirect comparisons. A com-
parison of estimates for direct and indirect evidence with
direct evidence only, show that the same conclusions
would be made for either form of evidence for all agents
with the exception of placebo cream versus no treatment
(Additional file 10). This indicates an increased uncer-
tainty about the NMA results that involve ‘no treatment’
in their network, as is the case with 1 % lidocaine and
1 % buffered lidocaine. This discrepancy may be due to
the inability to blind participants who receive no placebo
treatment prior to cannulation.
Additionally, the observation from the NMA that
Ametop® and EMLA® may be equally effective is an in-
teresting one. This is because Ametop® has both a
shorter time of onset (30–45 min compared with
60 min), and provides anaesthesia for longer (4–6 h
compared with up to 1 h). Furthermore, Ametop® is a
vasodilator, which may aid cannulation, whereas EMLA®
is a vasoconstrictor.
Results comparing the pain of local anaesthetic with
that of routine (non-emergency) unattenuated PVC in
adults (Question 2), suggest that the pain of a local
anaesthetic application is considerably less than that
of cannulation; this includes injections. This finding
counters the objection to providing pain relief for
PVC that ‘two sticks are worse than one’. Our evi-
dence suggests that this is not the case and that the
‘caine’ based anaesthetics, should be used to reduce
the pain of adult PVC.
These findings are further supported by a survey from
Brown (n = 180), which examined patient preferences for
receiving a lidocaine injection prior to PVC. Participants
were assigned to either having or not having lidocaine
prior to their PVC. Following cannulation they were
asked whether they would like to have this local anaes-
thetic if they needed PVC again. Brown found that par-
ticipants who were given lidocaine for their current or
previous PVC were more likely to want it next time
than those who had never had lidocaine for PVC
(current 96 %, previous 80 % and never 50 %). Only 4 %
of those who received lidocaine said that they would
not want it again [57].
Additional backing for the acceptability of lidocaine
injections comes from Levitt et al. who offered a con-
venience sample of 30 patients the choice of lidocaine,
guided imagery or nothing prior to routine PVC. All of
those who chose lidocaine said they were satisfied with
the intravenous (IV) insertion compared to half of those
who chose no pain relief [58].
While this systematic review has the strength of being
conducted by an independent research team; it has some
limitations. The searches were limited to studies pub-
lished from 1990 onwards, thus we only included data
from the last 25 years. However, 1990 has become a
fairly standard cut-off date and it was felt that it was
unlikely that any large trials had been missed.
Additionally this systematic review posed a number of
challenges to faithfully interpreting the data we found.
These included multiple pain models in a variety of
participants: different cannula sizes; different anatomical
locations; different indications to IV start; no within-
participant comparisons of pain intensity; unspecified
experience of the cannulator; different ages; genders and
unspecified concurrent cognitive behavioural interven-
tions. Further, there were multiple analgesic interventions
for the treatment groups and different interventions for
the control groups, including: no control intervention, pla-
cebo controlled intervention, active control intervention
(comparator pharmaceuticals). Four groups received pre-
medication, and there were multiple active interventions
with different mechanism of action, and modes of admin-
istration (topical/intradermal). In addition, different pain
intensity outcome tools were used in the studies that re-
quired some to be recalibrated to a metric scale and trans-
forming medians to means. Furthermore, many of the
comparisons in the NMA were informed by just one or
two studies, with many studies being very small. It is there-
fore difficult to know whether the lack of evidence for dif-
ferences between many of the treatments is really a lack of
a difference or whether there is not enough power to iden-
tify any difference in this analysis. The authors acknow-
ledge that these challenges to synthesizing the data and
interpreting the outcomes will increase the uncertainty of
our results due to their varying impact on efficacy.
Furthermore, systematic reviews are susceptible to
publication bias and bias towards a larger effect size that
may come from smaller studies, both of which will favour
the intervention. We have not been able to formally inves-
tigate the risk of publication bias in this review, and so
there may be a possibility that we have overestimated the
benefit of local anaesthetic. The searches included those
for unpublished studies in an attempt to address this issue;
no includable studies were found.
Conclusions
Routine adult PVC should include local anaesthesia
similar to paediatric practice. Evidence suggests that the
pain of PVC can be successfully reduced and that the
means to do this is either painless or the discomfort of
the procedure is acceptable and more acceptable than
the pain of PVC. The experience of pain has significance
beyond the particular occasion because it can increase
anxiety and fear about further treatment and deter
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people from seeking help in the future [2–5]. The choice
of local anaesthetic may be determined by practical and
clinical considerations. Hospital protocols and medical
and nursing training should be altered to reflect this.
The use of local anaesthetic for routine adult PVC
should be used as a care quality marker.
Further research
Resources for further research should be directed towards
the following:
 a cost-effectiveness analysis of local anaesthetics
including lidocaine injection, Ametop® and EMLA®,
Including the duration of pain relief and the utility
value;
 implementation research to investigate the
barriers to changing practice and how these can
be overcome; and,
 studies that quantify the impact of local anaesthetic
for PVC on long-term needle phobia and seeking
medical help for health concerns.
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